Kay / Pwodwi yo / Syans lavi / Lòt Byochimik / Sanisfè

Pwodwi yo

CAS:157115-85-0 (S)-etil 2-(1-({2-phenylacetyl)pyrrolidine-2-carboxamido)acetate

CAS:157115-85-0 (S)-etil 2-(1-({2-phenylacetyl)pyrrolidine-2-carboxamido)acetate

Non:(S)-etil 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate
CAS:157115-85-0
Pite: Pi gran pase oswa egal a 98 pousan
Fòmil molekilè: C17H22N2O4
Pwa molekilè: 318.37
Pwen k ap fonn: N/A
Pwen bouyi: 547.3ºC nan 760mmHg

Voye rechèch

Livrezon atravè lemond
Kalite asirans
Sèvis Kliyan 24/7

Pwodwi Entwodiksyon

Deskripsyon

Noopept (Ris: Ноопепт; GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester) se yon peptide ankouraje ak preskri nan Larisi ak peyi vwazen kòm yon nootropic. Non mak ki anrejistre Noopept (Ноопепт) se yon mak pa manifakti JSC LEKKO Pharmaceuticals. Se konpoze an patante nan tou de US la ak Larisi ak patant nan Federasyon Larisi nimewo 2119496, US Patant 5,439,930 bay 8/8/1995. Li vann kòm yon sipleman dyetetik nan peyi Etazini ak kòm yon medikaman nan lòt peyi yo.

Non:(S)-etil 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate	Sinonim:2-[(2S)-1-(2-fenilasetil)pirolidin-2-karbonil]amino]acetate etil
CAS:157115-85-0	Pite:Pi gran pase oswa egal a 98 pousan
Fòmil molekilè:C₁₇H₂₂N₂O₄	Pwa molekilè:318.37
Pwen fizyon:N/A	Pwen bouyi:547.3ºC nan 760mmHg
Flash Pwen:284.8ºC	PSA:75.71000
LogP:1.22820	Aparans:poud blan
Dansite:1.202g / cm3	Estabilite:Pwoteje kont lè ak limyè
Solibilite:DMSO (25 mg/ml)	endèks refraktif:1.548
Presyon vapè:4.93E-12mmHg nan 25 degre	Kondisyon depo:0 degre (kout tèm), -20 degre (long tèm), siye
InChi:InChI{{0}}S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h 3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1
InChi kle:PJNSMUBMSNAEEN-AWEZNQCLSA-